Abstract #0076

Gadoxetate-enhanced abbreviated MRI is reliable and effective for HCC surveillance in high-risk patients.

Ryan L Brunsing¹, Dennis Chen¹, Alexandra Schlein¹, Paul Murphy², Yesenia Covarrubias¹, Alex Kuo³, Michel Mendler⁴, Irene Vodkin⁴, Rohit Loomba⁴, Yuko Kono⁴, and Claude B Sirlin¹

¹Liver Imaging Group, University of California San Diego, San Diego, CA, United States, ²Radiology, University of California San Diego, San Diego, CA, United States, ³Gastroenterology and Hepatology, Virginia Mason Medical Center, Seattle, WA, United States, ⁴Hepatology, University of California San Diego, San Diego, CA, United States

Gadoxetate enhanced abbreviated MRI (AMRI) is a simple, rapid acquisition protocol aimed at reducing the cost and increasing the throughput of MRI-based HCC surveillance. Here we analyze 330 consecutive patients with cirrhosis or chronic HBV who underwent at least one screening AMRI. The rate of HCC detected at cross sectional analysis (3.3%) was in line with published incidence of HCC, while the technical failure rate was low (5.8%) despite high prevalence of cirrhosis and ascites. Longitudinal analysis demonstrated high sensitivity, specificity, and negative predictive value in HCC detection, using a composite reference standard.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.